Fair Value Calculator Fair Value Calculator
EN DE

PT Central Proteina Prima Tbk, (CPRO) Fair Value & Analysis

Consumer Defensive · ID · Market cap 3.0T IDR

PC PT Central Proteina Prima Tbk, CPRO · JK
Price50.00 IDR
Fair Value125.94 IDR
Upside+151.9%
Quality50/100
Watch PT Central Proteina Prima Tbk, for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range 75.25 IDR – 186.68 IDR

Fair value as of: Jul 5, 2026

From 25 valuation models · updated today

Fair value updated Jul 5, 2026 — revised from 185.38 IDR to 125.94 IDR (−32.1%) since Jun 24, 2026.

Price vs Fair Value (12 months)

86.00 IDR 50.00 IDR Fair Value 125.94 IDR Jul 2025 Jul 2026

12‑month range 50.00 IDR – 86.00 IDR · fair‑value band 75.25 IDR – 186.68 IDR · the 50.00 IDR price screens below the 125.94 IDR fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

PT Central Proteina Prima Tbk, (CPRO) currently trades at 50.00 IDR, while our model-based Fair Value estimate is 125.94 IDR — implying the stock looks roughly 151.9% undervalued today. We read business quality at 50/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, PT Central Proteina Prima Tbk, generated revenue of 10.0T IDR at a net margin of 3.6%. Revenue grew 3.1% year over year. It earns a return on equity of 9.6%. Net debt stands at 1.5T IDR. Fundamentals as of Jul 5, 2026

Our scenario range runs from 75.25 IDR (bear case) to 186.68 IDR (bull case); at 50.00 IDR, the current price sits below that range. The share trades about 43% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -19% fair-value upside — at 152%, CPRO screens cheaper than that median.

Key figures & financial health

Revenue (TTM) 10.0T IDR
Revenue growth (YoY) +3.1%
Net margin 3.6%
Return on equity 9.6%
Free cash flow 142B IDR FY2025
P/E ratio 8.2
More key figures
Operating margin 7.2%
EPS (TTM) 6.10 IDR
EPS growth (YoY) -37.5%
Net debt 1.5T IDR FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

About the company

PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture shrimp and food producer company in Indonesia, India, Vietnam, China, Japan, the United States, Canada, the United Kingdom, Belgium, France, the Netherlands, Germany, and New Zealand. The company operates through Feeds, Food Products, and Others segments. It engages in the industry, livestock and agriculture, farming, hatchery, and trading and services, as well as production and trading of shrimp, fish feeds and pet food. The company also offers shrimp feed, fish feed, cat food, dog food, fish food, bird food, rabbit food, probiotic products, fish additives, disinfectants, fish hatchery, shrimp hatchery, medicines for shrimp and fish, and probiotic for shrimp medicines, as well as is involved in the cold storage and trading of shrimp, and an investment holding business. The company was formerly known as PT Central Proteinaprima Tbk and changed its name to PT Central Proteina Prima …

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

PT Central Proteina Prima Tbk, reported revenue of 9.9T IDR in FY2025 versus 8.0T IDR in FY2021, a compound +5.5%/yr. Reported net income was 424B IDR in FY2025, compounding −33.8%/yr from FY2021.

Revenue +5.5%/yr
FY21 8.0T IDR
FY22 8.2T IDR
FY23 9.0T IDR
FY24 9.3T IDR
FY25 9.9T IDR
Net income −33.8%/yr
FY21 2.2T IDR
FY22 374B IDR
FY23 401B IDR
FY24 320B IDR
FY25 424B IDR

Is CPRO fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "PT Central Proteina Prima Tbk, Fair Value". https://www.fairvalue-calculator.com/stock/CPRO

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).

Stock Price Fair Value vs Fair Value
Archer-Daniels-Midland Company ADM $81.28 $38.31 -53%
Muyuan Foods Group 002714 ¥35.06 ¥49.23 +40%
Bunge Global SA BG $129.13 $136.85 +6%
Tyson Foods, Inc TSN $58.73 $34.80 -41%
Wens Foodstuff Group 300498 ¥12.89 ¥6.35 -51%
Mowi ASA MOWI kr 190.10 kr 134.90 -29%
SalMar ASA SALM kr 541.00 kr 171.05 -68%
Fujian Wanchen Food Group 300972 ¥177.00 ¥143.09 -19%
PT Charoen Pokphand Indonesia Tbk, CPIN 3,240 IDR 5,212 IDR +61%
Charoen Pokphand Foods Public Company CPF 19.20 THB 57.92 THB +202%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is PT Central Proteina Prima Tbk, (CPRO) undervalued?
As of Jul 5, 2026, our model estimates a fair value of 125.94 IDR versus a price of 50.00 IDR — about +152% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CPRO?
Our model-based fair value for PT Central Proteina Prima Tbk, is 125.94 IDR (as of Jul 5, 2026), built from audited fundamentals. The current price is 50.00 IDR.
What is the quality score of CPRO?
PT Central Proteina Prima Tbk, has a Quality Score of 50/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of PT Central Proteina Prima Tbk, (CPRO)?
PT Central Proteina Prima Tbk, reported trailing-twelve-month revenue of about 10.0T IDR (latest available figure, as of Jul 5, 2026).
What is the net profit margin of CPRO?
The net profit margin of PT Central Proteina Prima Tbk, is about 3.6%, meaning it keeps roughly 3.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.